Poxel S.A.
PXXLFOTCHealthcare
$0.26
+$0.00(+0.00%)
Market Cap$15876379
P/E Ratio—
52W High$0.7
52W Low$0.25
Poxel S.A. (PXXLF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PXXLF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2025Report Date: Jun 30, 2025EPS Actual
-$0.59
Revenue
$0.01B
Fiscal Period
Q2 FY2025
FY ends December
Report Date
Jun 30, 2025
After Market Close
✓ 1-Quarter EPS Beat Streak
PXXLF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 23, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Sep 23, 2026 | — | — | — | — | — | — |
| — Q2 FY2025 | Jun 30, 2025 | — | -$0.59 | — | $0.01B | — | — |
| — Q2 FY2025 | Apr 22, 2025 | — | -$0.28 | — | $0.01B | — | — |
| — Q4 FY2024 | Dec 9, 2024 | — | -$0.18 | — | $0.00B | — | — |
| ▲ Q2 FY2024 | Jun 20, 2024 | -$0.42 | -$0.31 | +26.9% | $0.00B | $0.00B | +182.4% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -$0.46 | -$0.90 | -96.9% | $0.00B | $0.00B | -36.3% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -$0.25 | -$0.66 | -169.8% | $0.00B | $0.00B | -0.9% |
Q3 FY2026
Sep 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Sep 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Jun 30, 2025
EPS Actual
-$0.59
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2025
Apr 22, 2025
EPS Actual
-$0.28
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2024
Dec 9, 2024
EPS Actual
-$0.18
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Jun 20, 2024Beat
EPS Actual
-$0.31
EPS Est.
-$0.42
EPS Surpr.
+26.9%
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023Miss
EPS Actual
-$0.90
EPS Est.
-$0.46
EPS Surpr.
-96.9%
Revenue
$0.00B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
-$0.66
EPS Est.
-$0.25
EPS Surpr.
-169.8%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2023 | $-0.37 | $-0.37 | $-0.37 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2025 | Jun 30, 2025 | — | $0.25 | $0.25 | +0.00% |
| — Q2 FY2025 | Apr 22, 2025 | — | $0.25 | $0.25 | +0.00% |
| — Q4 FY2024 | Dec 9, 2024 | — | $0.25 | $0.25 | +0.00% |
| ▲ Q2 FY2024 | Jun 20, 2024 | +26.9% | $0.70 | $0.70 | +0.00% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -96.9% | $2.60 | $2.60 | +0.00% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -169.8% | $2.60 | $2.60 | +0.00% |
| ▲ Q4 FY2022 | Oct 4, 2022 | +27.8% | $2.60 | $2.60 | +0.00% |
| ▲ Q2 FY2022 | May 17, 2022 | +44.1% | $2.10 | $2.10 | +0.00% |
Q2 FY2025+0.00%
Report Date
Jun 30, 2025
EPS Beat/Miss
—
Price Before
$0.25
Price After
$0.25
Q2 FY2025+0.00%
Report Date
Apr 22, 2025
EPS Beat/Miss
—
Price Before
$0.25
Price After
$0.25
Q4 FY2024+0.00%
Report Date
Dec 9, 2024
EPS Beat/Miss
—
Price Before
$0.25
Price After
$0.25
Q2 FY2024+0.00%
Report Date
Jun 20, 2024
EPS Beat/Miss
+26.9%
Price Before
$0.70
Price After
$0.70
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
-96.9%
Price Before
$2.60
Price After
$2.60
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
-169.8%
Price Before
$2.60
Price After
$2.60
Q4 FY2022+0.00%
Report Date
Oct 4, 2022
EPS Beat/Miss
+27.8%
Price Before
$2.60
Price After
$2.60
Q2 FY2022+0.00%
Report Date
May 17, 2022
EPS Beat/Miss
+44.1%
Price Before
$2.10
Price After
$2.10
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate3 / 8 quarters
Largest Move+0.00% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PXXLF ends December
Poxel S.A. (PXXLF) most recently reported earnings on June 30, 2025 for Q2 FY2025, posting EPS of $-0.59 (in line with the analyst consensus of —). The next PXXLF earnings date is expected around September 1, 2026.
Each quarter, investors track PXXLF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PXXLF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PXXLF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PXXLF earnings · 4 questionsPoxel S.A.'s next earnings report is expected around September 1, 2026. PXXLF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PXXLF historically reports after market close (AMC).
PXXLF earnings datewhen is PXXLF earningsPXXLF next earnings datewhen does PXXLF report earningsPXXLF earnings calendar
▸ Source: FMP · Poxel S.A. SEC filings · US GAAP · Poxel S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026